Adam W. Oaks - Concepedia

Author

Adam W. Oaks

Georgetown University

Also Known As

Adam Oaks, Adam W Oaks, Adam W. Oaks, Adam W. Oaks (334539)

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Georgetown University Georgetown University Medical Center University of California San Diego George Washington University Johns Hopkins University

About

Adam W. Oaks is an author at Georgetown University specializing in medicine, neurodegenerative diseases, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	376
2	Social Sciences	4	4	202
3	Cell Biology	4	4	299
4	Allergy	1	1	111
5	Biochemistry	1	1	77

Adam W. Oaks

Publications

981

Citations

H-Index

Page 1

	Year	Citations
Phylum- and Class-Specific PCR Primers for General Microbial Community Analysis Christopher B. Blackwood, Adam W. Oaks, Jeffrey S. Buyer Applied and Environmental Microbiology	2005	132
Age-Dependent Effects of A53T Alpha-Synuclein on Behavior and Dopaminergic Function Adam W. Oaks, Maya Frankfurt, David I. Finkelstein, PLoS ONE	2013	123
Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease Thomas Haggerty, Joel J. Credle, Olga Rodriguez, European Journal of Neuroscience	2011	122
Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases Valeriy Duka, Jae‐Hoon Lee, Joel J. Credle, PLoS ONE	2013	112
Paraquat, but Not Maneb, Induces Synucleinopathy and Tauopathy in Striata of Mice through Inhibition of Proteasomal and Autophagic Pathways Jonathan Wills, Joel J. Credle, Adam W. Oaks, PLoS ONE Synaptic TransmissionImmunologyNeurochemical BiomarkersSynaptic SignalingAutophagy Inhibitor	2012	111
α-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease Joel J. Credle, Patrick A. Forcelli, Michael Delannoy, Neurobiology of Disease Neurodegenerative DiseasesSignal TransductionSynaptic Signalingα-Synuclein-mediated InhibitionCell Death	2015	105
Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease Jonathan Wills, Joel J. Credle, Thomas Haggerty, PLoS ONE Neurochemical BiomarkersTauopathic ChangesSynaptic SignalingSocial SciencesAlzheimer's Disease	2011	77
Cc2d1a Loss of Function Disrupts Functional and Morphological Development in Forebrain Neurons Leading to Cognitive and Social Deficits Adam W. Oaks, Marta Zamarbide, Dimira Tambunan, Cerebral Cortex Developmental Cognitive NeuroscienceBrain DevelopmentCc2d1a LossNeurotransmissionCellular Neurobiology	2016	48
Male-Specific cAMP Signaling in the Hippocampus Controls Spatial Memory Deficits in a Mouse Model of Autism and Intellectual Disability Marta Zamarbide, Adele Mossa, Pablo Muñoz-LLancao, Biological Psychiatry Cognitive ScienceDevelopmental BiologyBrain FunctionDevelopmental Cognitive NeuroscienceCortical Remodeling	2018	42
Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease Tiffany Kaul, Joel J. Credle, Thomas Haggerty, BMC Neuroscience	2011	37

Page 1